CRISPR Therapeutics's Finance department is led by Samarth Kulkarni (Chief Executive Officer, President) and has 19 employees.
Raju Prasad
Chief Financial Officer
Geoffrey Wild
Director of Quality Control
Andrew Silver
Vice President Corporate Finance
Rachel Eides
Director, Investor Relations & Corporate Communications
Paul Sullivan
Senior Director of Market Access
John Gazley
Director of Financial Planning and Analysis
Mary Cornwell
Associate Director, Reporting and Technical Accounting
Brendan Smith
Chief Executive Officer
Beverly Gaal
Sr. Manager
Erica Pascocello
Senior Accountant
Daniel Roth
Accounts Payable Specialist
Looking for a particular CRISPR Therapeutics employee's phone or email?